2024 news

World-renowned actor of film and stage, Dame Judi Dench, has become Patron of the Yorkshire Macular Degeneration Fund, aimed at supporting research into vision loss and blindness.

A University of York spin-out company is partnering with a top US Cancer Centre to test a biomarker for early detection of lung cancer.

Researchers have developed a water sensor that makes it possible to monitor bacterial contamination in real time.

Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body’s immune response, bringing a vaccine for the neglected tropical disease a step closer.

A new study on live tissue cells is the first to reveal how channels that allow sodium to enter into breast cancer cells enable tumours to grow and spread.

Hear more about Professor Rob Newton's journey as a researcher how he ended up doing the work that he does and what motivates it.

A new technology aims to take gene therapies a step further, making it possible for the treatment to be used more widely, at lower cost, and with improved outcomes for patients.

York Biomedical Research Institute colleagues are part of a prize-winning international research network.

Researchers at the University of York are to be part of BBSRC-funded project to investigate the use Artificial Intelligence for structural determination of biomolecules.

Dr Alyssa Cull is a postdoctoral researcher in Professor Dave Kent’s lab, at the Centre for Blood Research (CBR). Hear more about her journey in academia so far, and how the CBR is contributing to her future as a blood cancer researcher.

New research into acute myeloid leukaemia (AML), led by Dr Juliana Fabiani Miranda, could identify better ways to attack childhood AML cells and will set the foundations for future research by providing data about cancer cells' weaknesses. This research has been funded thanks to two Children’s Cancer and Leukaemia Group (CCLG) Special Named Funds.

Scientists from the University of York are working with doctors and patients at York Hospital to understand the DNA mutations linked to a group of chronic blood cancers, and investigate why, in some cases, they can suddenly become more aggressive.

A new study carried out by researchers at the University of York suggests 28% of people who catch COVID-19 will go on to suffer from Long Covid.

Naj Modak meets researchers Dr Steven Quinn and Professor Thomas Krauss at the University of York. Their research team is working to develop a blood test which they believe could diagnose Alzheimer's earlier. The team hope light-based technology could detect protein levels which are associated with the disease in a patient's blood. They are developing a handheld device to diagnose patients within seconds.

A York academic has had a third paper published in one of the world’s most high-impact psychiatry journals, the Lancet Psychiatry.

The Jack Birch Unit were visited by Dr David McConkey, the Director of the Johns Hopkins Greenberg Bladder Cancer Institute and Professor in the Department of Urology at Johns Hopkins Medical School.

Researchers at the University of York are using light-based technology to develop a simple and cost-effective blood test for Alzheimer’s disease.

As countries begin to vaccinate children against malaria, hopes are growing that vaccines against other human parasites could soon be within reach. Read more about the leishmaniasis vaccine that Professor Paul Kaye (HYMS) has been developing

A researcher from the Department of Psychology is to receive funding from The Academy of Medical Sciences Springboard scheme for emerging leaders.

Researchers in the Departments of Chemistry and Biology have discovered a previously unreported class of enzymes, involved in the assembly of a sugar on the surface of a pathogenic bacteria that targets vulnerable patients in hospital.

Watch the YorkTalks video from Professor Adele Fielding and find out how her experience is helping harness the three cornerstones of research into blood diseases – basic science, clinical trials and epidemiology.

At the 2024 edition of YorkTalks, Professor Luke Alphey presented his work on how biotechnologies can re-programme parts of the mosquito’s DNA code to reduce its ability to transmit disease.

Endometriosis takes an average of 6.6 years to be diagnosed worldwide, with delays of up to 27 years reported in the UK, researchers at the University of York have found.

The Cryo-EM facility and Viking cluster in York have played a major role in increasing understanding of bacterial cells’ ability to survive when threatened; understanding which could lead to more effective medicines in the future.

Researchers at York Biomedical Research Institute, in collaboration with the University of Dundee have determined how a highly selective protein bridge allows cells to express a single gene from a large gene family.

A University of York spin-out company aims to produce a novel treatment created from engineered human stem cells in the fight against arthritic disease in both adults and children.